dokumendiregister.ee
Sissetulev kiriAvalik

Euroopa farmakopöa töökava asjus

Ravimiamet · 5. märts 2025
Viit
REP-1/1198-1
Registreeritud
5. märts 2025
Dokumendi liik
Sissetulev kiri
Adressaat
European Directorate for the Quality of Medicines & HealthCare
Saabumis/saatmisviis
e-post
Funktsioon
REP Euroopa Farmakopöaga seotud asjaajamine
Sari
REP-1 Euroopa Farmakopöa alane kirjavahetus
Toimik
REP-1/2025
Vastutaja
Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)

Failid

Sisu (failidest)

Signe Leito Saatja: [email protected] Saatmisaeg: kolmapäev, 5. veebruar 2025 17:17 Adressaat: Signe Leito Teema: Proposed addition of a new monograph to the work programme of Group 10A: Thalidomide: EDQM-2025-00602-mail Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Please make sure to include in any reply our mail reference: EDQM-2025-00602-mail **************************************************************************** European Pharmacopoeia Commission Secretariat RZ/PH/ 2025-00590L Strasbourg, 5 February 2025 JSB/mk FOR THE ATTENTION OF NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed addition of the monograph Thalidomide to the work programme of Group 10A. In order to have access to the survey, please copy and paste this link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=173761&lang=en Deadline for replies: 7 March 2025 With kind regards, On behalf of Dr Jaume SANZ-BISET 1 Mireille KOPF Assistant - European Pharmacopoeia Department EDQM - Council of Europe 7 Allee Kastner Cs-30026 F-67081 Strasbourg France Tel. : +33 (0)3 88 41 28 53 [email protected] www.edqm.eu **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-00602-mail 2
Allikas: Ravimiamet dokumendiregister →